The new Radiation Research and Translational Biology, (RRTB) program integrates elements from three prior Kimmel Cancer Center programs: Structural Biology and Bioinformatics Program, Developmental Therapeutics Program, and Hematological Malignancies and Stem Cell Transplantation Program. This restructuring was undertaken to leverage key strengths of clinical research at the KCC in Radiation Oncology, Hematological Malignancies, and Stem Cell Transplantation to create a program that conducts bench to bedside research with sustained return of clinical data to the bench in the form of reverse translation. The central themes of the new program include angiogenesis, stem cell function and microenvironmental mediators of the radiation response. The RRTB is an interdisciplinary program comprised of basic, translational and clinical investigators from eight departments and multiple areas of active investigation, interest and expertise. Their work is supported by $18 million in peer-reviewed funding ($16.0 M from NCI). The total number of publications of Program members is 940 of which 16% are Intraprogrammmatic and 14% are Interprogrammatic. The program is a multidisciplinary effort with the goal of defining fundamental mechanisms and targets in radiation research and translational biology, which can facilitate innovations in treating cancer in patients. The specific goals of the RRTB Program are: (1) Define and characterize molecular targets for ionizing radiation. (2) Hypoxia and Angiogenesis: Elucidate mechanisms regulating HIF, integrate angiogenesis inhibitors with ionizing radiation and preclinical and clinical imaging of angiogenesis. (3) Study normal tissue injury/genotoxic stress. (4) Understand radiation target elucidation and modification and (5) Discover and translate diagnostic and therapeutic innovations developed in the laboratories of KCC members to clinical practice. This new program has generated new collaborations within the program and fresh research directions with other research programs in the cancer center.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Thomas Jefferson University
United States
Zip Code
Wirblich, Christoph; Coleman, Christopher M; Kurup, Drishya et al. (2017) One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus. J Virol 91:
Mikkilineni, Lekha; Whitaker-Menezes, Diana; Domingo-Vidal, Marina et al. (2017) Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment. Semin Oncol 44:218-225
Monti, Daniel; Sotgia, Federica; Whitaker-Menezes, Diana et al. (2017) Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer. Semin Oncol 44:226-232
Weinberg, David S; Lin, Jieru E; Foster, Nathan R et al. (2017) Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention. Cancer Prev Res (Phila) 10:345-354
Mitra, Ramkrishna; Chen, Xi; Greenawalt, Evan J et al. (2017) Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition. Nat Commun 8:1604
Curry, Joseph; Johnson, Jennifer; Tassone, Patrick et al. (2017) Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial. Laryngoscope 127:1808-1815
Overmiller, Andrew M; Pierluissi, Jennifer A; Wermuth, Peter J et al. (2017) Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes. FASEB J 31:3412-3424
Paolillo, Carmela; Mu, Zhaomei; Rossi, Giovanna et al. (2017) Detection of Activating Estrogen Receptor Gene (ESR1) Mutations in Single Circulating Tumor Cells. Clin Cancer Res 23:6086-6093
Jiang, Wei; Dulaimi, Essel; Devarajan, Karthik et al. (2017) Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma. Oncotarget 8:37423-37434
Cheng, Hanyin; Chua, Vivian; Liao, Connie et al. (2017) Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma. Mol Cancer Ther 16:516-528

Showing the most recent 10 out of 777 publications